1. Home
  2. HXHX vs BMRA Comparison

HXHX vs BMRA Comparison

Compare HXHX & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HXHX

Haoxin Holdings Limited Class A Ordinary Shares

HOLD

Current Price

$0.54

Market Cap

8.1M

Sector

Industrials

ML Signal

HOLD

Logo Biomerica Inc.

BMRA

Biomerica Inc.

HOLD

Current Price

$2.15

Market Cap

7.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HXHX
BMRA
Founded
2003
1971
Country
China
United States
Employees
N/A
N/A
Industry
Trucking Freight/Courier Services
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.1M
7.7M
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
HXHX
BMRA
Price
$0.54
$2.15
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.7M
8.2K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$5,311,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$1.96
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.33
$0.40
52 Week High
$2.15
$4.60

Technical Indicators

Market Signals
Indicator
HXHX
BMRA
Relative Strength Index (RSI) 52.70 38.57
Support Level $0.49 $2.11
Resistance Level $0.55 $2.40
Average True Range (ATR) 0.09 0.12
MACD 0.01 -0.00
Stochastic Oscillator 54.00 29.55

Price Performance

Historical Comparison
HXHX
BMRA

About HXHX Haoxin Holdings Limited Class A Ordinary Shares

Haoxin Holdings Ltd is engaged in the logistics industry, including container provider of temperature-controlled truckload service and urban delivery services in China, freight forwarding, cold chain transportation and other businesses. The types of goods involved are all kinds of new energy materials that require low temperature, heat preservation, and constant temperature, electronic products, medicines, meat, fruits, vegetables and others.

About BMRA Biomerica Inc.

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.

Share on Social Networks: